Literature DB >> 22039872

Non-classical structures among current platinum complexes with potential as antitumor drugs.

Adoracion G Quiroga1.   

Abstract

The potential and limitations of the non classical metallodrugs with platinum as metal are discussed in this section, focusing not only in their design but in their mechanism of action and interaction with other biomolecules to introduce and encourage the readers on the potential of this field.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22039872     DOI： 10.2174/156802611798040723

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN： 1568-0266            Impact factor:   3.295


  3 in total

1.  Nucleotide Binding Preference of the Monofunctional Platinum Anticancer-Agent Phenanthriplatin.

Authors:  Imogen A Riddell; Timothy C Johnstone; Ga Young Park; Stephen J Lippard
Journal:  Chemistry       Date:  2016-04-25       Impact factor: 5.236

2.  Interaction of the New Monofunctional Anticancer Agent Phenanthriplatin With Transporters for Organic Cations.

Authors:  Anna Hucke; Ga Young Park; Oliver B Bauer; Georg Beyer; Christina Köppen; Dorothea Zeeh; Christoph A Wehe; Michael Sperling; Rita Schröter; Marta Kantauskaitè; Yohannes Hagos; Uwe Karst; Stephen J Lippard; Giuliano Ciarimboli
Journal:  Front Chem       Date:  2018-05-25       Impact factor: 5.221

3.  Pt(iv) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action.

Authors:  Raji Raveendran; Jeremy Phillip Braude; Ezequiel Wexselblatt; Vojtech Novohradsky; Olga Stuchlikova; Viktor Brabec; Valentina Gandin; Dan Gibson
Journal:  Chem Sci       Date:  2016-01-15       Impact factor: 9.825
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.